Alzheimers & Dementia-Translational Research & Clinical Interventions

Scope & Guideline

Advancing Knowledge, Improving Lives in Dementia Care

Introduction

Immerse yourself in the scholarly insights of Alzheimers & Dementia-Translational Research & Clinical Interventions with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN-
PublisherWILEY
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationALZH DEMENT-TRCI / Alzheimers Dement.-Transl. Res. Clin. Interv.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal 'Alzheimers & Dementia: Translational Research & Clinical Interventions' focuses on bridging the gap between basic research and clinical applications in the field of Alzheimer's disease and related dementias. It aims to provide a platform for innovative research that offers insights into the pathophysiology, diagnosis, treatment, and care of Alzheimer's disease.
  1. Clinical Applications of Biomarkers:
    The journal emphasizes research on biomarkers that can aid in the diagnosis and monitoring of Alzheimer's disease. This includes studies on cerebrospinal fluid (CSF) biomarkers, plasma markers, and neuroimaging techniques to track disease progression.
  2. Pharmacological Interventions:
    A significant focus is on the development and evaluation of pharmacological treatments, including anti-amyloid therapies and other disease-modifying agents. This encompasses clinical trials and their design, efficacy, and safety.
  3. Social and Behavioral Aspects of Dementia Care:
    Research related to the psychosocial aspects of dementia care, including caregiver support, patient-centered care strategies, and the impact of social connections on health outcomes is a core area of interest.
  4. Health Disparities and Inclusion:
    The journal addresses issues of diversity and inclusion in Alzheimer's research, emphasizing the importance of studying underrepresented populations and understanding how social determinants affect health outcomes.
  5. Innovative Methodologies:
    The journal promotes the use of novel methods in Alzheimer's research, including machine learning, digital health technologies, and community-based participatory research approaches.
The journal has seen a rise in themes that reflect contemporary issues and advancements in Alzheimer's research. These emerging areas indicate a shift towards more integrative and inclusive approaches to understanding and treating the disease.
  1. Diversity and Inclusion in Research:
    There is an increasing emphasis on the importance of diversity in research populations, addressing health disparities, and ensuring that findings are applicable across different racial, ethnic, and socio-economic groups.
  2. Digital Health Interventions:
    The trend towards digital health solutions, including telehealth, mobile health applications, and online cognitive training programs, is gaining traction as a means to enhance patient engagement and accessibility.
  3. Personalized Medicine Approaches:
    Research that aims to tailor interventions based on individual genetic, biomarker, and lifestyle profiles is on the rise, highlighting a shift towards personalized treatment strategies for Alzheimer's disease.
  4. Holistic and Multidimensional Care Models:
    There is a growing focus on holistic care models that integrate physical, mental, and social health, recognizing the multifaceted nature of dementia and its impact on overall well-being.
  5. Community-Based Participatory Research:
    Increasingly, research methodologies that involve community engagement and collaboration with stakeholders are emerging, reflecting a commitment to addressing real-world challenges faced by individuals with dementia and their caregivers.

Declining or Waning

As the landscape of Alzheimer's research evolves, certain themes within the journal have shown a decline in prominence. This may reflect shifting priorities or advancements in other areas of research.
  1. Traditional Neuropsychological Assessments:
    There appears to be a waning focus on traditional neuropsychological assessments as primary outcomes in Alzheimer's studies, with a shift towards more dynamic and holistic measures of cognition and functionality.
  2. Single-Domain Interventions:
    Research concentrating solely on single-domain interventions, such as cognitive training or pharmacological treatments without integrated approaches, is decreasing as multidisciplinary strategies become more favored.
  3. Cultural Competency Training:
    While once a focal point, specific studies on cultural competency training for dementia care providers are becoming less frequent, possibly as the field moves towards broader systemic changes rather than isolated training programs.
  4. Basic Mechanistic Studies:
    Research centered exclusively on basic mechanistic studies without translational implications is declining, as there is a stronger emphasis on studies that can directly inform clinical practice and patient outcomes.
  5. Epidemiological Studies on Non-Dementia Populations:
    There is a noticeable reduction in studies focusing on the epidemiology of cognitive decline in non-dementia populations, as the journal pivots towards more targeted research on individuals diagnosed with Alzheimer's disease.

Similar Journals

Dementia and Geriatric Cognitive Disorders Extra

Exploring innovative research in geriatric neuroscience.
Publisher: KARGERISSN: Frequency: 3 issues/year

Dementia and Geriatric Cognitive Disorders Extra, published by KARGER in Switzerland, is an esteemed open-access journal dedicated to advancing research in the fields of cognitive neuroscience, geriatrics, and psychiatry. With a commitment to disseminating high-quality research since its inception in 2011, the journal plays a crucial role in highlighting innovative studies that address cognitive disorders associated with aging. As an open-access platform, it ensures that findings are accessible to a global audience, fostering collaboration and knowledge-sharing among researchers, professionals, and students alike. The journal has been recognized for its impact in Cognitive Neuroscience and Psychiatry and Mental Health, achieving a Q3 category ranking, indicating its reputable standing within these fields. By delivering cutting-edge insights and promoting interdisciplinary approaches, Dementia and Geriatric Cognitive Disorders Extra is instrumental in enhancing understanding and treatment of cognitive decline, making it a vital resource for anyone engaged in the study of aging and cognitive health.

Cerebral Circulation-Cognition and Behavior

Advancing Insights into Brain, Behavior, and Beyond
Publisher: ELSEVIERISSN: 2666-2450Frequency: 1 issue/year

Cerebral Circulation-Cognition and Behavior is an impactful journal published by Elsevier that focuses on the intersections of cerebral circulation, cognitive function, and behavioral science. Since its establishment in 2020, the journal has provided a vital platform for researchers and professionals in the fields of Behavioral Neuroscience, Biological Psychiatry, and Cognitive Neuroscience. With a current classification in the Q3 quartile across several neuroscience categories and a promising trajectory during its converged years (2020-2024), the journal highlights significant advancements in our understanding of the neural underpinnings of behavior. Although it is not open access, its commitment to quality research makes it an essential resource for anyone engaged in neurological, cognitive, and psychiatric studies. As discoveries in these fields continue to grow, Cerebral Circulation-Cognition and Behavior remains dedicated to disseminating influential findings that bridge the gap between cognition, behavior, and neural health.

BMC Geriatrics

Advancing knowledge for a healthier aging population.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Geriatrics is a leading open-access journal dedicated to advancing the field of geriatrics and gerontology. Published by BMC, this esteemed journal has been at the forefront of research since its inception in 2001, providing a vital platform for sharing innovative studies and insights that address the complexities of aging. With an impressive Q1 ranking in the 2023 category of Geriatrics and Gerontology and a solid Scopus ranking at #40 out of 116, BMC Geriatrics showcases high-impact research that influences clinical practices and policy-making. As a fully open-access publication, it ensures that groundbreaking research is freely available to researchers, practitioners, and students alike, promoting the diffusion of knowledge across the global healthcare community. This journal is crucial for anyone interested in the latest developments in elderly care, health issues affecting aging populations, and innovative interventions designed to improve quality of life among older adults.

Quality in Ageing and Older Adults

Elevating Gerontology Through Scholarly Contributions
Publisher: EMERALD GROUP PUBLISHING LTDISSN: 1471-7794Frequency: 4 issues/year

Quality in Ageing and Older Adults is an esteemed journal published by Emerald Group Publishing Ltd, dedicated to elucidating the complexities and challenges of aging and the quality of life for older adults. With a focus on critical areas within Care Planning, Community and Home Care, and Gerontology, this journal serves as a vital resource for researchers, healthcare professionals, and students alike. Recognized for its scholarly contributions, it holds a Q2 ranking for Care Planning and Community and Home Care and maintains an impactful presence in Gerontology, further demonstrated by its Scopus rankings. Although the journal does not offer open access, its commitment to advancing knowledge in the field is underscored by its ongoing publication since 2000 and its broad scholarly reach until 2024. By fostering innovative research and practical insights, Quality in Ageing and Older Adults continues to play a crucial role in informing policy, enhancing care practices, and improving outcomes for older individuals.

ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Pioneering research on Alzheimer’s and its complexities.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0893-0341Frequency: 4 issues/year

ALZHEIMER DISEASE & ASSOCIATED DISORDERS, published by Lippincott Williams & Wilkins, is a pivotal journal for advancing knowledge in the fields of clinical psychology, geriatric medicine, and psychiatry. With a history spanning from 1987 to 2024, this journal provides a comprehensive platform for researchers and clinicians to disseminate significant findings related to Alzheimer's disease and associated cognitive disorders. Ranked within the second and third quartiles in various categories, including clinical psychology and geriatrics, it retains a solid academic reputation, indicated by its diverse Scopus rankings, such as #137 in Clinical Psychology and #20 in Nursing & Gerontology. Although it does not offer open access, the journal is recognized for its commitment to peer-reviewed research, making it a valuable resource for professionals and students alike, aiming to stay abreast of the latest developments and evidence-based practices in Alzheimer’s and associated conditions.

Annals of Geriatric Medicine and Research

Advancing knowledge in geriatric care.
Publisher: KOREAN GERIATRIC SOCISSN: 2508-4909Frequency: 4 issues/year

Annals of Geriatric Medicine and Research, published by the Korean Geriatric Society, is a premier open-access journal dedicated to advancing the understanding of geriatric medicine and gerontology. Since its inception in 1997, the journal has played a crucial role in disseminating significant research findings, policy discussions, and clinical innovations that address the complexities of elderly healthcare. Based in South Korea, the journal has gained recognition with an impact factor reflecting its Q2 ranking in the field of Geriatrics and Gerontology for 2023, placing it competitively within its category among 116 journals. Researchers, healthcare professionals, and students will find comprehensive insights ranging from clinical studies to public health strategies crucial for enhancing the quality of life of older adults. With a commitment to open access, the journal ensures that its valuable information is freely available, fostering collaboration and knowledge-sharing that is vital in this dynamic field.

Current Treatment Options in Rheumatology

Advancing rheumatology through innovative treatment insights.
Publisher: SPRINGERNATUREISSN: Frequency: 4 issues/year

Current Treatment Options in Rheumatology, published by SPRINGERNATURE, is a pivotal journal focused on advancing the field of rheumatology through the dissemination of cutting-edge research and comprehensive reviews. With an emphasis on current therapeutic strategies, this journal aims to provide healthcare professionals, researchers, and students with up-to-date information on the latest treatment modalities for rheumatic diseases. Although it operates under a subscription model, it offers a platform for sharing significant findings that can influence clinical practice and policy within the field of rheumatology. By promoting insightful discussions and collaborations, Current Treatment Options in Rheumatology plays a crucial role in shaping the future of rheumatic disease management and improving patient outcomes.

Dementia-International Journal of Social Research and Practice

Empowering practitioners with high-impact dementia studies.
Publisher: SAGE PUBLICATIONS LTDISSN: 1471-3012Frequency: 8 issues/year

Dementia - International Journal of Social Research and Practice, published by SAGE Publications Ltd, is a premier peer-reviewed journal dedicated to advancing research in the multifaceted arena of dementia care and social interventions. Founded in 2002, this journal has steadily established itself as a key resource for academics and practitioners alike, reflected by its esteemed rankings in the Q1 category across multiple disciplines, including History, Medicine (Miscellaneous), Social Sciences (Miscellaneous), and Sociology and Political Science. With a remarkable Scopus rank of #28 in General Social Sciences and a 90th percentile standing, the journal champions high-impact articles that address the complexities of dementia through interdisciplinary lenses. Although it is not an open-access publication, it provides invaluable insights and cutting-edge research to its subscribers and contributors. This journal is pivotal for anyone engaged in dementia research and practice, offering not only findings from empirical studies but also fostering dialogue on social policies and care practices that enhance the lives of those affected by dementia.

JOURNAL OF ALZHEIMERS DISEASE

Advancing the understanding of Alzheimer's disease.
Publisher: IOS PRESSISSN: 1387-2877Frequency: 24 issues/year

Journal of Alzheimer's Disease, published by IOS Press, stands as a pivotal resource in the fight against Alzheimer's and related neurodegenerative disorders. With an ISSN of 1387-2877 and an E-ISSN of 1875-8908, this esteemed journal has evolved since its inception in 1998, providing a vital platform for academic research and clinical practice in the realms of Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Ranked in the Q1 category across several disciplines, including Clinical Psychology and Geriatrics, this journal not only highlights significant advancements in understanding Alzheimer's disease but also fosters interdisciplinary dialogue among researchers, healthcare professionals, and policymakers. Boasting robust Scopus rankings—such as 49th in Clinical Psychology and 29th in Geriatrics—this journal is committed to disseminating high-quality research that informs both therapeutic strategies and public health initiatives. The Journal of Alzheimer's Disease is an essential resource for anyone dedicated to exploring the complexities of cognitive decline and enhancing care for affected individuals.

Progress in Neurology and Psychiatry

Enhancing care through cutting-edge research and discourse.
Publisher: JOHN WILEY & SONS LTDISSN: 1367-7543Frequency: 4 issues/year

Progress in Neurology and Psychiatry is a pivotal journal published by John Wiley & Sons Ltd, dedicated to advancing the fields of neurology and psychiatry. With a robust history dating back to its establishment, this esteemed journal holds a consistent Q3 ranking in 2023 across several categories including Neurology, Clinical Neurology, Psychiatry, and Mental Health, signifying its significant contribution to the scientific community. This journal serves as a vital source of knowledge and insight, publishing original research, reviews, and case studies that explore the intricacies of neurological and psychiatric disorders. Although it does not offer open access, the journal remains accessible to a wide audience through institutional subscriptions. By fostering a platform for scholarly discourse, Progress in Neurology and Psychiatry aims to bridge the gap between research and practice, ultimately enhancing the quality of care for individuals with neurological and psychiatric conditions. Researchers, clinicians, and students are encouraged to engage with the journal's comprehensive content to stay informed of the latest developments and emerging trends in these critical fields of medicine.